{
    "nctId": "NCT04241341",
    "briefTitle": "Does Immediate Lymphatic Reconstruction Decrease the Risk of Lymphedema After Axillary Lymph Node Dissection",
    "officialTitle": "A Randomized Controlled Trial: Does Immediate Lymphatic Reconstruction Decrease the Incidence of Lymphedema After Axillary Lymph Node Dissection",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Cancer Lymphedema",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 180,
    "primaryOutcomeMeasure": "the number of patients that had a decrease incidence of lymphedema",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female breast cancer patients 18-75 years of age\n* Patients consenting for unilateral ALND (prior history of SLNBx allowed if \\<6 months from consent) OR patients consenting for unilateral SLNBx with possible ALND, with a clinically or radiographically positive lymph node OR a high likelihood of ALND per the Breast Surgeon\n* Identification of at least one transected lymphatic channel and at least one vein to be used for bypass at the time of ALND during surgery\n\nExclusion Criteria:\n\n* Male breast cancer patients\n* Non-English speaking participants\n* Female breast cancer patients with axillary recurrence\n* Female breast cancer patients who have a history of ALND\n* Female patients requiring bilateral ALND for the treatment of their breast cancer\n* Female breast patients treated with SLNBx only",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}